Tag: Sean Bohen
AstraZeneca, Amgen asthma drug tezepelumab secures FDA breakthrough designation
UK biopharma company AstraZeneca and Amgen have secured breakthrough therapy designation from the US Food and Drug Administration (FDA) for their asthma drug tezepelumab. The ... Read More
CHMP recommends AstraZeneca lung cancer drug Imfinzi EMA approval
Update on Imfinzi EMA approval : The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ... Read More